AI filing briefs · archive

8-K filings in August 2024, explained

352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

2 of 352 briefs match

newest first · times in ET

AORTARTIVION, INC. Aug 8, 4:06 PM ET

Artivion Q2 revenue rises 10% to $98.0 million; raises 2024 revenue and EBITDA outlook

Positive guidance Written later 2.02

Artivion reported second-quarter 2024 revenue of $98.0 million, up 10% from $89.3 million a year earlier, and a net loss of $2.1 million ($0.05 per diluted share), narrower than the $3.4 million loss ($0.08 per share) in the prior-year quarter. The company raised its full-year 2024 revenue and adjusted EBITDA guidance, though the increases at the midpoint are small.

Q2 2024 revenue $98.0 million vs. $89.3 million in Q2 2023, up 10% on both GAAP and constant currency bases
Q2 2024 net loss of $2.1 million ($0.05 per diluted share) vs. net loss of $3.4 million ($0.08 per share) in Q2 2023; non-GAAP net income $2.9 million ($0.07 per share)
Adjusted EBITDA rose 35% to $18.6 million from $13.8 million
FY24 revenue guidance raised to $388 million to $396 million from $386 million to $396 million; adjusted EBITDA guidance raised to $69 million to $72 million from $68 million to $72 million

Read the filing on SEC.gov ↗

YETIYETI Holdings, Inc. Aug 8, 6:08 AM ET

YETI raises 2024 outlook after second-quarter sales rise 15% to $463.5 million

Positive guidance Written later 2.02

YETI reported second-quarter 2024 net sales up 15% to $463.5 million, or 9% on an adjusted basis that excludes a 2023 recall reserve adjustment, and GAAP diluted EPS of $0.59, up from $0.44. The company raised its fiscal 2024 adjusted sales growth outlook to 8% to 10% and its adjusted EPS outlook to $2.61 to $2.65, which matters to shareholders because it signals higher expected profit for the year.

Net sales rose 15% to $463.5 million; adjusted net sales rose 9% after excluding the $24.5 million unfavorable recall reserve impact in the prior-year quarter.
GAAP diluted EPS was $0.59 versus $0.44; adjusted EPS was $0.70 versus $0.57.
Fiscal 2024 adjusted EPS outlook raised to $2.61 to $2.65, from $2.49 to $2.62 previously.
Cash was $212.9 million at June 29, 2024, and $200 million remained under the share repurchase program.

Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.